NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease.

作者: Patricia F. Coogan , Lynn Rosenberg , Carol Louik , Ann G. Zauber , Paul D. Stolley

DOI: 10.1023/A:1008931708716

关键词: CancerMedicineOncologyOdds ratioColorectal cancerEpidemiologyCase-control studyPopulationDiseaseInternal medicineFamily history

摘要: Background:We undertook the present analyses to determine whether family history of colorectal cancer in a parent or sibling modifies inverse association nonsteroidal anti-inflammatory drug (NSAID) use with risk. Methods:We used data from two case–control studies cancer. The hospital-based Case Control Surveillance Study included 1526 patients primary cancer, 4192 controls and 6036 noncancer controls. A population-based study conducted Massachusetts enrolled 1201 incident cases community Data on NSAID risk factors for were collected by interview. Results:In both there was reduction odds ratios among subjects who NSAIDs regularly continuing into previous year, regardless history. In Case–Control data, ratio 0.4 (95% CI 0.2–0.9) 0.5 0.4–0.7) without comparable 0.3–0.9) 0.7 0.6–0.9). Conclusions:These indicate that regular is associated reduced persons disease, as well those such

参考文章(29)
Hixson Lj, Earnest Dl, Fennerty Mb, Sampliner Re, NSAID effect on sporadic colon polyps. The American Journal of Gastroenterology. ,vol. 88, pp. 1652- 1656 ,(1993)
Samuel Shapiro, Case–Control Surveillance John Wiley & Sons, Ltd. pp. 209- 230 ,(2002) , 10.1002/0470842555.CH13
Denis Labayle, Daniel Fischer, Philippe Vielh, Francois Drouhin, Alex Pariente, Christian Bories, Olivier Duhamel, Michel Trousset, Pierre Attali, Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology. ,vol. 101, pp. 635- 639 ,(1991) , 10.1016/0016-5085(91)90519-Q
Lucy A. Peipins, Robert S. Sandler, Epidemiology of Colorectal Adenomas Epidemiologic Reviews. ,vol. 16, pp. 273- 297 ,(1994) , 10.1093/OXFORDJOURNALS.EPIREV.A036154
John D. Potter, Martha L. Slattery, Roberd M. Bostick, Susan M. Gapstur, Colon Cancer: A Review of the Epidemiology Epidemiologic Reviews. ,vol. 15, pp. 499- 545 ,(1993) , 10.1093/OXFORDJOURNALS.EPIREV.A036132
Monica M. Bertagnolli, Maria Abreu-Goris, Susan K. Boolbol, Amy Chadburn, John T. Ramonetti, Harold L. Newmark, Charles Martucci, Martin L. Lipkin, Andrew J. Dannenberg, XiaoJun Guo, Jerome J. DeCosse, Cyclooxygenase-2 Overexpression and Tumor Formation Are Blocked by Sulindac in a Murine Model of Familial Adenomatous Polyposis Cancer Research. ,vol. 56, pp. 2556- 2560 ,(1996)
N Matsuhashi, A Nakajima, Y Fukushima, Y Yazaki, T Oka, Effects of sulindac on sporadic colorectal adenomatous polyps. Gut. ,vol. 40, pp. 344- 349 ,(1997) , 10.1136/GUT.40.3.344
U. Metzger, J. Meier, G. Uhlschmid, H. Weihe, Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Diseases of The Colon & Rectum. ,vol. 27, pp. 366- 369 ,(1984) , 10.1007/BF02553001
G.M Petersen, Genetic Epidemiology of Colorectal Cancer European Journal of Cancer. ,vol. 31, pp. 1047- 1050 ,(1995) , 10.1016/0959-8049(95)00156-D